These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21167566)

  • 1. Prognostic effect of urinary bladder carcinoma in situ on clinical outcome of subsequent upper tract urothelial carcinoma.
    Youssef RF; Shariat SF; Lotan Y; Wood CG; Sagalowsky AI; Zigeuner R; Langner C; Montorsi F; Bolenz C; Margulis V
    Urology; 2011 Apr; 77(4):861-6. PubMed ID: 21167566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concomitant carcinoma in situ and tumour size are prognostic factors for bladder recurrence after nephroureterectomy for upper tract transitional cell carcinoma.
    Pieras E; Frontera G; Ruiz X; Vicens A; Ozonas M; Pizá P
    BJU Int; 2010 Nov; 106(9):1319-23. PubMed ID: 20394618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
    Saito K; Kawakami S; Fujii Y; Sakura M; Masuda H; Kihara K
    J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
    Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
    J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifocal carcinoma in situ of the upper tract is associated with high risk of bladder cancer recurrence.
    Xylinas E; Rink M; Margulis V; Karakiewicz P; Novara G; Shariat SF;
    Eur Urol; 2012 May; 61(5):1069-70. PubMed ID: 22402109
    [No Abstract]   [Full Text] [Related]  

  • 6. Outcome in patients with exclusive carcinoma in situ (CIS) after radical cystectomy.
    Zehnder P; Moltzahn F; Daneshmand S; Leahy M; Cai J; Miranda G; Bartsch G; Mitra AP; Skinner DG; Skinner EC; Gill IS
    BJU Int; 2014 Jan; 113(1):65-9. PubMed ID: 23937628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk profiles of three clinical types of carcinoma in situ of the bladder.
    Meijer RP; van Onna IE; Kok ET; Bosch R
    BJU Int; 2011 Sep; 108(6):839-43. PubMed ID: 21166747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy.
    Wheat JC; Weizer AZ; Wolf JS; Lotan Y; Remzi M; Margulis V; Wood CG; Montorsi F; Roscigno M; Kikuchi E; Zigeuner R; Langner C; Bolenz C; Koppie TM; Raman JD; Fernández M; Karakiewizc P; Capitanio U; Bensalah K; Patard JJ; Shariat SF
    Urol Oncol; 2012; 30(3):252-8. PubMed ID: 20451416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superficial transitional cell carcinoma of the ureteral orifice: higher risk of developing subsequent upper urinary tract tumors.
    Chou EC; Lin AT; Chen KK; Chang LS
    Int J Urol; 2006 Jun; 13(6):682-5. PubMed ID: 16834642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upper urinary tract tumors after primary superficial bladder tumors: prognostic factors and risk groups.
    Millán-Rodríguez F; Chéchile-Toniolo G; Salvador-Bayarri J; Huguet-Pérez J; Vicente-Rodríguez J
    J Urol; 2000 Oct; 164(4):1183-7. PubMed ID: 10992362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
    Sanderson KM; Cai J; Miranda G; Skinner DG; Stein JP
    J Urol; 2007 Jun; 177(6):2088-94. PubMed ID: 17509294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic management of upper tract urothelial carcinoma in patients with a history of bladder urothelial carcinoma.
    Krambeck AE; Thompson RH; Lohse CM; Patterson DE; Segura JW; Zincke H; Elliott DS; Blute ML
    J Urol; 2007 May; 177(5):1721-6. PubMed ID: 17437796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy.
    Shariat SF; Palapattu GS; Karakiewicz PI; Rogers CG; Vazina A; Bastian PJ; Schoenberg MP; Lerner SP; Sagalowsky AI; Lotan Y
    Eur Urol; 2007 Jan; 51(1):152-60. PubMed ID: 17011114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of bacille Calmette-Guérin perfusion therapy for treatment of transitional cell carcinoma in situ of upper urinary tract.
    Hayashida Y; Nomata K; Noguchi M; Eguchi J; Koga S; Yamashita S; Hayashi M; Kanatake H
    Urology; 2004 Jun; 63(6):1084-8. PubMed ID: 15183955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes mellitus with poor glycemic control increases bladder cancer recurrence risk in patients with upper urinary tract urothelial carcinoma.
    Tai YS; Chen CH; Huang CY; Tai HC; Wang SM; Pu YS
    Diabetes Metab Res Rev; 2015 Mar; 31(3):307-14. PubMed ID: 25363092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of factors predicting intravesical recurrence of superficial transitional cell carcinoma of the bladder without concomitant carcinoma in situ.
    Sakai I; Miyake H; Harada K; Hara I; Inoue TA; Fujisawa M
    Int J Urol; 2006 Nov; 13(11):1389-92. PubMed ID: 17083389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Micropapillary urothelial carcinoma of the urinary bladder: a clinicopathological analysis of 72 cases.
    Compérat E; Roupret M; Yaxley J; Reynolds J; Varinot J; Ouzaïd I; Cussenot O; Samaratunga H
    Pathology; 2010 Dec; 42(7):650-4. PubMed ID: 21080874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between gender and outcome of patients with upper tract urothelial cancer.
    Chou YH; Chang WC; Wu WJ; Li CC; Yeh HC; Hou MF; Chou PS; Lee MH; Chang WP; Li WM
    Kaohsiung J Med Sci; 2013 Jan; 29(1):37-42. PubMed ID: 23257255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients.
    Tilki D; Reich O; Svatek RS; Karakiewicz PI; Kassouf W; Novara G; Ficarra V; Chade DC; Fritsche HM; Gerwens N; Izawa JI; Lerner SP; Schoenberg M; Stief CG; Skinner E; Lotan Y; Sagalowsky AI; Shariat SF
    J Urol; 2010 May; 183(5):1757-63. PubMed ID: 20299059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival of patients with carcinoma in situ of the urinary bladder.
    Cheng L; Cheville JC; Neumann RM; Leibovich BC; Egan KS; Spotts BE; Bostwick DG
    Cancer; 1999 Jun; 85(11):2469-74. PubMed ID: 10357420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.